Np mrd loader

Record Information
Version2.0
Created at2023-12-21 00:00:49 UTC
Updated at2024-09-03 04:18:33 UTC
NP-MRD IDNP0332246
Natural Product DOIhttps://doi.org/10.57994/1432
Secondary Accession NumbersNone
Natural Product Identification
Common NameIpriflavone
DescriptionIpriflavone, also known as osten or FL-113, belongs to the class of organic compounds known as isoflavones. These are polycyclic compounds containing a 2-isoflavene skeleton which bears a ketone group at the C4 carbon atom. Ipriflavone has been described as a phytoestrogen. Ipriflavone is an extremely weak basic (essentially neutral) compound (based on its pKa). The drug prevents bone loss via mechanisms that are distinct from those of estrogens. A double-blind study reveals that ipriflavone might be effective on reducing tinnitus on otosclerosis sufferers. A clinical trial reported in 2001 that it was not effective in prevention or treatment of osteoporosis. Ipriflavone (INN, JAN; brand name Yambolap) is a synthetic isoflavone which may be used to inhibit bone resorption, maintain bone density and to prevent osteoporosis in postmenopausal women. However, this is incorrect, as the drug does not bind to or activate the estrogen receptor and shows no estrogenic effects in postmenopausal women. It is not used to treat osteoporosis. Ipriflavone was first documented in 2001 (PMID: 11255425). It slows down the action of the osteoclasts (bone-eroding cells), possibly allowing the osteoblasts (bone-building cells) to build up bone mass (PMID: 23265084) (PMID: 17297162) (PMID: 21594876) (PMID: 24084576).
Structure
Thumb
Synonyms
ValueSource
7-(1-Methylethoxy)-3-phenyl-4H-1-benzopyran-4-oneChEBI
7-IsopropoxyisoflavoneChEBI
FL-113ChEBI
IpriflavonaChEBI
IpriflavonumChEBI
IprostenChEBI
OstenChEBI
YambolapChEBI
(Ipriflavone)HMDB
3-Phenyl-7-(propan-2-yloxy)-4H-chromen-4-oneHMDB
7-Isopropoxy-3-phenyl-4H-1-benzopyran-4-oneHMDB
FL113HMDB
Ipriflavone, innHMDB
OsteochinHMDB
OsteofixHMDB
OsteoquineHMDB
QuinoginHMDB
Chemical FormulaC18H16O3
Average Mass280.3178 Da
Monoisotopic Mass280.10994 Da
IUPAC Name3-phenyl-7-(propan-2-yloxy)-4H-chromen-4-one
Traditional Nameosten
CAS Registry NumberNot Available
SMILES
CC(C)OC1=CC2=C(C=C1)C(=O)C(=CO2)C1=CC=CC=C1
InChI Identifier
InChI=1S/C18H16O3/c1-12(2)21-14-8-9-15-17(10-14)20-11-16(18(15)19)13-6-4-3-5-7-13/h3-12H,1-2H3
InChI KeySFBODOKJTYAUCM-UHFFFAOYSA-N
Experimental Spectra
Spectrum TypeDescriptionDepositor EmailDepositor OrganizationDepositorDeposition DateView
HSQC NMR[1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental)bgnzk@missouri.eduMU Metabolomics Center, University of Missouri, Columbia. MO, USADr. Bharat Goel2024-05-02View Spectrum
HMBC NMR[1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental)bgnzk@missouri.eduMU Metabolomics Center, University of Missouri, Columbia. MO, USADr. Bharat Goel2024-05-02View Spectrum
COSY NMR[1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental)bgnzk@missouri.eduMU Metabolomics Center, University of Missouri, Columbia. MO, USADr. Bharat Goel2024-05-02View Spectrum
1D NMR13C NMR Spectrum (1D, 201 MHz, CD3OD, experimental)bgnzk@missouri.eduMU Metabolomics Center, University of Missouri, Columbia. MO, USADr. Bharat Goel2024-05-02View Spectrum
1D NMR1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental)bgnzk@missouri.eduMU Metabolomics Center, University of Missouri, Columbia. MO, USADr. Bharat Goel2024-05-02View Spectrum
Predicted Spectra
Spectrum TypeDescriptionDepositor IDDepositor OrganizationDepositorDeposition DateView
Chemical Shift Submissions
Spectrum TypeDescriptionDepositor EmailDepositor OrganizationDepositorDeposition DateView
1D NMR1H NMR Spectrum (1D, 600.133705802, CD3OD, simulated)bgnzk@missouri.eduSumner Lab, MU Metabolomics Center, University of Missouri, Columbia. MO, USADr. Bharat Goel2024-05-02View Spectrum
Species
Species of OriginNot Available
Chemical Taxonomy
Description Belongs to the class of organic compounds known as isoflavones. These are polycyclic compounds containing a 2-isoflavene skeleton which bears a ketone group at the C4 carbon atom.
KingdomOrganic compounds
Super ClassPhenylpropanoids and polyketides
ClassIsoflavonoids
Sub ClassIsoflav-2-enes
Direct ParentIsoflavones
Alternative Parents
Substituents
  • Isoflavone
  • Chromone
  • Benzopyran
  • 1-benzopyran
  • Alkyl aryl ether
  • Pyranone
  • Monocyclic benzene moiety
  • Pyran
  • Benzenoid
  • Heteroaromatic compound
  • Oxacycle
  • Ether
  • Organoheterocyclic compound
  • Organooxygen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Organic oxygen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External Descriptors
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP4.39ALOGPS
logP3.95ChemAxon
logS-4.8ALOGPS
pKa (Strongest Basic)-4.7ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area35.53 ŲChemAxon
Rotatable Bond Count3ChemAxon
Refractivity81.37 m³·mol⁻¹ChemAxon
Polarizability30.91 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
HMDB IDHMDB0032987
DrugBank IDDB13618
Phenol Explorer Compound IDNot Available
FoodDB IDFDB010976
KNApSAcK IDNot Available
Chemspider ID3616
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkIpriflavone
METLIN IDNot Available
PubChem Compound3747
PDB IDNot Available
ChEBI ID31719
Good Scents IDNot Available
References
General References
  1. Bae M, Woo M, Kusuma IW, Arung ET, Yang CH, Kim YU: Inhibitory effects of isoflavonoids on rat prostate testosterone 5alpha-reductase. J Acupunct Meridian Stud. 2012 Dec;5(6):319-22. doi: 10.1016/j.jams.2012.07.022. Epub 2012 Aug 9. [PubMed:23265084 ]
  2. Alexandersen P, Toussaint A, Christiansen C, Devogelaer JP, Roux C, Fechtenbaum J, Gennari C, Reginster JY: Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. JAMA. 2001 Mar 21;285(11):1482-8. doi: 10.1001/jama.285.11.1482. [PubMed:11255425 ]
  3. Yao J, Zhang J, Hou JF: Effects of ipriflavone on caged layer bone metabolism in vitro and in vivo. Poult Sci. 2007 Mar;86(3):503-7. doi: 10.1093/ps/86.3.503. [PubMed:17297162 ]
  4. Yun C, Ding L, Leng Y, Zhu H, Wen A, Yang L: Determination of ipriflavone in human plasma by LC-MS and its application in a pharmacokinetic study. Biomed Chromatogr. 2012 Jan;26(1):123-8. doi: 10.1002/bmc.1641. Epub 2011 May 19. [PubMed:21594876 ]
  5. Xiao Z, Huang C, Wu J, Sun L, Hao W, Leung LK, Huang J: The neuroprotective effects of ipriflavone against H (2)O (2) and amyloid beta induced toxicity in human neuroblastoma SH-SY5Y cells. Eur J Pharmacol. 2013 Dec 5;721(1-3):286-93. doi: 10.1016/j.ejphar.2013.09.023. Epub 2013 Sep 29. [PubMed:24084576 ]